Stay updated on Glycine Supplement for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.

Latest updates to the Glycine Supplement for Severe COVID-19 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision stamp updated from v3.6.5 to v3.6.6, signaling a small metadata update to the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows a generic error message stating the page is unavailable, replacing the usual study details with a standard error block.SummaryDifference21%

- Check47 days agoChange DetectedThe footer now shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating a minor site update.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, indicating a new version of the content.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a newer release of the page content.SummaryDifference0.0%

- Check89 days agoChange DetectedRecruitment is now marked as closed for this study, and new help/navigation sections were added while an old Intervention / Treatment heading formatting was removed, reflecting UI/structure updates rather than changes to the study data.SummaryDifference0.5%

Stay in the know with updates to Glycine Supplement for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.